KMT2A and neoplasm: The oncogenic role of ZEB1 in AML is more controversial, as Almotiri et al. recently postulated that ZEB1 may act as a tumor suppressor given that murine Zeb1 deletion in MLL-AF9 models can accelerate AML progression [129].